Clinical Trial Update: Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a long-acting follicle-stimulating hormone for infertile women undergoing assisted reproductive technology has been completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Elonva (corifollitropin alfa)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility | Phase 2 | Status: COMPLETED | Results posted: 2013-07-24